Cargando…

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Is Associated With Subsequent Hospitalization for Heart Failure

BACKGROUND: Hospitalization for heart failure (HHF) is among the most important problems confronting medicine. Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) robustly identifies intrinsic myocardial damage. LGE may indicate inherent vulnerability to HHF, regardless of etio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Timothy C., Piehler, Kayla M., Zareba, Karolina M., Lin, Kathie, Phrampus, Ashley, Patel, Agam, Moon, James C., Ugander, Martin, Valeti, Uma, Holtz, Jonathan E., Fu, Bo, Chang, Chung‐Chou H., Mathier, Michael, Kellman, Peter, Butler, Javed, Gheorghiade, Mihai, Schelbert, Erik B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886781/ https://www.ncbi.nlm.nih.gov/pubmed/24249712 http://dx.doi.org/10.1161/JAHA.113.000416

Ejemplares similares

Myocardial fibrosis is associated with subsequent death and hospitalization for heart failure in obese adults
por: Fridman, Yaron, et al.
Publicado: (2015)

Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
por: Schelbert, Erik B., et al.
Publicado: (2015)

Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography
por: Wong, Timothy C, et al.
Publicado: (2013)

Extracellular volume MRI increases the detection of myocardial abnormalities beyond late gadolinium enhancement - initial findings
por: Lundin, Magnus, et al.
Publicado: (2012)

Think Small and Examine the Constituents of Left Ventricular Hypertrophy and Heart Failure: Cardiomyocytes Versus Fibroblasts, Collagen, and Capillaries in the Interstitium
por: Schelbert, Erik B, et al.
Publicado: (2015)

Understanding why edema in salvaged myocardium is difficult to detect by late gadolinium enhancement
por: Ugander, Martin, et al.
Publicado: (2012)

Feasibility of the REDCap platform for Single Center and Collaborative Multicenter CMR Research
por: Wong, Timothy C, et al.
Publicado: (2014)

Impact of cardiovascular imaging on the management of patients with cardiac masses
por: Chang, Ian C, et al.
Publicado: (2016)

Synthetic phase sensitive inversion recovery late gadolinium enhancement from post-contrast T1-mapping shows excellent agreement with conventional PSIR-LGE for diagnosing myocardial scar
por: Abdula, Goran, et al.
Publicado: (2014)

Cardiovascular magnetic resonance with late gadolinium enhancement improves mortality prediction beyond echocardiography: a comparative effectiveness study
por: Schelbert, Erik B, et al.
Publicado: (2012)

Myocardial fibrosis quantified by the extracellular extravascular volume fraction is associated with the left ventricular sphericity index and the left atrial volume index
por: Moguillansky, Diego, et al.
Publicado: (2012)

Prevalence and prognosis of non-ischemic patterns of late gadolinium enhancement in older adults by cardiovascular MR in the ICELAND-MI study
por: Shanbhag, Sujata M, et al.
Publicado: (2016)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Dark blood Late Gadolinium Enhancement improves conspicuity of ablation lesions
por: Kellman, Peter, et al.
Publicado: (2016)

Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality
por: Cardona, Andrea, et al.
Publicado: (2019)

Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus
por: Schelbert, Erik B, et al.
Publicado: (2011)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Magnetic resonance imaging of cardiac tumors: experience of a tertiary medical center
por: Chang, Ian C, et al.
Publicado: (2013)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

Acute heart failure syndromes
por: Gheorghiade, Mihai
Publicado: (2009)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
por: Schelbert, Erik B., et al.
Publicado: (2017)

In patients with acute myocarditis, the difference in apparent extracellular volume fraction between affected and healthy myocardium does not differ between early and late post-contrast imaging
por: Lundin, Magnus, et al.
Publicado: (2016)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
por: Giamouzis, Gregory, et al.
Publicado: (2016)

Automated inline extracellular volume (ECV) mapping
por: Spottiswoode, Bruce S, et al.
Publicado: (2015)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents
por: Hojreh, Azadeh, et al.
Publicado: (2020)

Extracellular volume fraction is associated with B-type natriuretic peptide in hypertrophic cardiomyopathy
por: Wong, Timothy C, et al.
Publicado: (2014)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar
por: Francis, Rohin, et al.
Publicado: (2017)

The dynamics of extracellular gadolinium-based contrast agent excretion into pleural and pericardial effusions quantified by T1 mapping cardiovascular magnetic resonance
por: Thalén, Simon, et al.
Publicado: (2019)

The utility of free-breathing, motion-corrected late gadolinium enhancement for right ventricular fibrosis imaging in congenital heart disease
por: Heng, Ee Ling, et al.
Publicado: (2015)

Dark blood late enhancement imaging
por: Kellman, Peter, et al.
Publicado: (2016)

Comparison of electroanatomic voltage mapping with late gadolinium enhancement CMR
por: Peters, Dana C, et al.
Publicado: (2014)

Respiratory bellows-gated left atrial late gadolinium enhancement
por: Peters, Dana C, et al.
Publicado: (2011)

Improved evaluation of left ventricular hypertrophy using the spatial QRS-T angle by electrocardiography
por: Maanja, Maren, et al.
Publicado: (2022)

Pulmonary artery pressure is associated with extracellular volume fraction in patients with normal left ventricular function
por: Cater, George M, et al.
Publicado: (2016)

Bright-blood and dark-blood phase sensitive inversion recovery late gadolinium enhancement and T1 and T2 maps in a single free-breathing scan: an all-in-one approach
por: Kellman, Peter, et al.
Publicado: (2021)

Measurement of the intracellular lifetime of water to estimate myocardial cell size is not feasible in humans using clinical contrast agent doses at 1.5T
por: Lundin, Magnus, et al.
Publicado: (2016)

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
por: Moon, James C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k1j5vhpqc7egn48r090pgk2d42